UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
The
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
July
24, 2014
DOLBY LABORATORIES, INC.
(Exact
name of registrant as specified in its charter)
Delaware |
001-32431 |
90-0199783 |
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
100 Potrero Avenue San Francisco, CA 94103-4813 |
(Address of principal executive offices) (Zip Code) |
(415)
558-0200
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 2 - Financial Information
ITEM 2.02 Results of Operations and Financial Condition.
The following information is intended to be furnished under Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
On July 24, 2014, Dolby Laboratories, Inc. issued a press release announcing its financial results for its fiscal quarter ended June 27, 2014. The full text of the press release is furnished as Exhibit 99.1 and is incorporated herein by reference.
Section 9 - Financial Statements and Exhibits
ITEM 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | ||
99.1 | Press Release of Dolby Laboratories, Inc. dated July 24, 2014 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DOLBY LABORATORIES, INC. |
||||
|
|
By: |
/s/ Lewis Chew |
|
Lewis Chew |
||||
Executive Vice President and Chief Financial Officer |
||||
Date: |
July 24, 2014 |
EXHIBIT INDEX
Exhibit |
Description |
99.1 |
Press Release of Dolby Laboratories, Inc. dated July 24, 2014 |